Search research articles
Contact Us
Filters
Showing results (341-350 of 427) with videos related to
Page
of 43
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy
Yuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 20, 2004
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease
Laura A Dawson, Naoyuki G Saito, Voravit Ratanatharathorn, et al.
EJNMMI Physics
|
December 1, 2018
Impact of <sup>90</sup>Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization
Justin K Mikell, Ravi K Kaza, Peter L Roberson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 13, 2005
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer
Mary Feng, Siavash Jabbari, Alexander Lin, et al.
Medical Physics
|
August 22, 2022
Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization
Daniel F Polan, Marina A Epelman, Victor W Wu, et al.
Radiology
|
May 1, 1994
Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy
H J van der Woude, J L Bloem, J Schipper, et al.
Translational Oncology
|
January 5, 2021
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy
Matthew M Cousins, Emily Morris, Christopher Maurino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2017
Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts
P S Boonstra, T M Braun, J M G Taylor, et al.
Breast Cancer Research and Treatment
|
January 7, 2014
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients
L M van Roozendaal, R J Schipper, K K B T Van de Vijver, et al.
American Journal of Clinical Oncology
|
July 14, 2015
Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy
Jessica Zhou, Charles X Fang, Jincheng Shen, et al.
Page
of 43
Search research articles
Search
Showing results (341-350 of 427) with videos related to
Sort By:
Page
of 43
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy
Yuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 20, 2004
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease
Laura A Dawson, Naoyuki G Saito, Voravit Ratanatharathorn, et al.
EJNMMI Physics
|
December 1, 2018
Impact of <sup>90</sup>Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization
Justin K Mikell, Ravi K Kaza, Peter L Roberson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 13, 2005
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer
Mary Feng, Siavash Jabbari, Alexander Lin, et al.
Medical Physics
|
August 22, 2022
Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization
Daniel F Polan, Marina A Epelman, Victor W Wu, et al.
Radiology
|
May 1, 1994
Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy
H J van der Woude, J L Bloem, J Schipper, et al.
Translational Oncology
|
January 5, 2021
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy
Matthew M Cousins, Emily Morris, Christopher Maurino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2017
Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts
P S Boonstra, T M Braun, J M G Taylor, et al.
Breast Cancer Research and Treatment
|
January 7, 2014
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients
L M van Roozendaal, R J Schipper, K K B T Van de Vijver, et al.
American Journal of Clinical Oncology
|
July 14, 2015
Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy
Jessica Zhou, Charles X Fang, Jincheng Shen, et al.
Page
of 43